Raymond James & Associates’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,134
| Closed | -$570K | – | 3963 |
|
|
2022
Q4 | $570K | Buy |
+21,134
| New | +$570K | ﹤0.01% | 2796 |
|
|
2021
Q3 | – | Sell |
-75,086
| Closed | -$1.71M | – | 4080 |
|
|
2021
Q2 | $1.71M | Sell |
75,086
-145
| -0.2% | -$3.3K | ﹤0.01% | 2207 |
|
|
2021
Q1 | $1.55M | Sell |
75,231
-12,224
| -14% | -$252K | ﹤0.01% | 2192 |
|
|
2020
Q4 | $2.42M | Sell |
87,455
-2,042
| -2% | -$56.4K | ﹤0.01% | 1778 |
|
|
2020
Q3 | $1.26M | Sell |
89,497
-4,296
| -5% | -$60.3K | ﹤0.01% | 2031 |
|
|
2020
Q2 | $1.93M | Buy |
93,793
+248
| +0.3% | +$5.11K | ﹤0.01% | 1747 |
|
|
2020
Q1 | $706K | Sell |
93,545
-10,407
| -10% | -$78.5K | ﹤0.01% | 2195 |
|
|
2019
Q4 | $1.61M | Buy |
+103,952
| New | +$1.61M | ﹤0.01% | 1955 |
|